HomeStockWeather reportNetworkAwardees

Stock

AllATCCBEI ClinicalHeatUSCD Clinical isolateUV-C

hCoV-19/USA/CA-CFAR-033515/2022

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
UV-C
GISAID:
BA.2.12.1 / Clade GRA
MSDS:
BA.2.12.1-UVI-Lot1-MSDS (January 1, 1970)

hCoV-19/USA/CA-SEARCH-205906/2022

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
Heat, UV-C
GISAID:
BF.7 / Clade GRA
MSDS:
BF.7-HTI-Lot1-MSDS (January 1, 1970)BF.7-UVI-Lot1-MSDS (January 1, 1970)

hCoV-19/Japan/TY7-503/2021 (Brazil P.1)

Benchmarked:
Availavility:
Now
Source:
BEI Clinical
Inactivation method:
UV-C, Heat
GISAID:
Lineage P.1 / Clade GR
MSDS:
P.1-UVInactivation-MSDS (January 1, 1970)P.1-HeatInactivation-MSDS (January 1, 1970)

hCoV-19/South Africa/KRISP-K005325/2020

Benchmarked:
Availavility:
Now
Source:
BEI Clinical
Inactivation method:
UV-C, Heat
GISAID:
Lineage B.1.351 / Clade GH
MSDS:
B.1.351-UVInactivation-MSDS (January 1, 1970)Product Group 200 Von Roll Schweiz AG (May 4, 2021)Corona Smoke Fluid 300C (May 1, 2021)B.1.351-HeatInactivation-MSDS (January 1, 1970)NATtrol Respiratory Validation Panel (May 17, 2021)

hCoV-19/USA/CA_UCSD_5574/2020

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
UV-C, Heat
GISAID:
Lineage B.1.1.7 / Clade GR
MSDS:
B.1.1.7-UVInactivation(lot2)-MSDS (January 1, 1970)B.1.1.7-HeatInactivation-MSDS (January 1, 1970)B.1.1.7-UVInactivation-MSDS (January 1, 1970)NATtrol Respiratory Validation Panel (May 17, 2021)

hCoV-19/USA/CA-CFAR-033518/2022

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
UV-C, Heat
GISAID:
BA.5.1 / Clade GRA
MSDS:
BA.5.1-UVI-Lot1-MSDS (January 1, 1970)BA.5.1-HTI-Lot1-MSDS (January 1, 1970)

hCoV-19/USA/CA-SEARCH-212968/2022

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
UV-C, Heat
GISAID:
BQ.1 / Clade GRA
MSDS:
BQ.1-UVI-Lot1-MSDS (January 1, 1970)BQ.1-HTI-Lot1-MSDS (January 1, 1970)

hCoV-19/USA/CA-SEARCH-221363/2022

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
Heat, UV-C
GISAID:
XBB.1.5 / Clade GRA
MSDS:
XBB.1.5-HTI-Lot1-MSDS (January 1, 1970)XBB.1.5-UVI-Lot1-MSDS (January 1, 1970)

hCoV-19/USA/CA-SEARCH-59467/2021

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
Heat, UV-C
GISAID:
BA.1 / Clade GRA
MSDS:
BA.1-HeatInactivation-MSDS (January 1, 1970)BA.1-UVInactivation-MSDS (January 1, 1970)

hCoV-19/USA/CA-SEARCH-59467/2021

Benchmarked:
Availavility:
Now
Source:
USCD Clinical isolate
Inactivation method:
UV-C
GISAID:
BA.1 / Clade GRA
MSDS:
BA.1-UVI-Lot2-MSDS (January 1, 1970)

hCoV-19/USA/PHC658/2021 (Delta Variant)

Benchmarked:
Availavility:
Now
Source:
BEI Clinical
Inactivation method:
UV-C, Heat
GISAID:
Lineage B.1.617.2
MSDS:
B.1.617.2-UVInactivation-MSDS (January 1, 1970)B.1.617.2-HeatInactivation-MSDS (January 1, 1970)

hCoV-229E

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
UV-C, Heat
MSDS:
229E-UVInactivation-MSDS (January 1, 1970)229E-HeatInactivation-MSDS (January 1, 1970)

hCoV-OC43

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
UV-C
MSDS:
OC43-UVInactivation-MSDS (January 1, 1970)

Influenza A (H1N1)

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
Heat, UV-C
MSDS:
Influenza A(H1N1)-HTI-Lot1-MSDS (January 1, 1970)Influenza A(H1N1)-UVI-Lot1-MSDS (January 1, 1970)

Influenza A (H3N2)

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
UV-C, Heat
MSDS:
Influenza A(H3N2)-UVInactivation-MSDS (January 1, 1970)Influenza A(H3N2)-HeatInactivation-MSDS (January 1, 1970)

Influenza B (2009)

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
Heat, UV-C
MSDS:
Influenza B(2009)-HeatInactivation-MSDS (January 1, 1970)Influenza B(2009)-UVInactivation-MSDS (January 1, 1970)

RSV A2

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
UV-C, Heat
MSDS:
RSV (A2)-UVInactivation-MSDS (January 1, 1970)RSV (A2)-HeatInactivation-MSDS (January 1, 1970)

RSV B

Benchmarked:
Availavility:
Now
Source:
ATCC
Inactivation method:
UV-C, Heat
MSDS:
RSV B(18537)-UVInactivation-MSDS (January 1, 1970)RSV B(18537)-HeatInactivation-MSDS (January 1, 1970)

SARS-CoV-2, isolate USA-WA1/2020

Benchmarked:
Availavility:
Now
Source:
BEI Clinical
Inactivation method:
UV-C
GISAID:
Lineage A / Clade S
MSDS:
WA1-UVI-Lot3-MSDS (January 1, 1970)WA1-UVI-Lot7-MSDS (January 1, 1970)WA1-UVI-Lot6-MSDS (January 1, 1970)

USA-WA1/2020

Benchmarked:
Availavility:
Now
Source:
BEI Clinical
Inactivation method:
UV-C, Heat
GISAID:
Lineage A / Clade S
MSDS:
WA1-UVInactvation-MSDS (January 1, 1970)Product Group 200 Von Roll Schweiz AG (May 4, 2021)WA1-UVI-Lot3-MSDS (January 1, 1970)WA1-HeatInactivation-MSDS (January 1, 1970)WA1-UVInactivation-(lot2)MSDS (January 1, 1970)